The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| APTOSE BIOSCIENCES INC | COM NEW | 03835T200 | 17,333 | 2,918,000 | SH | SOLE | 1 | 2,918,000 | 0 | 0 | |
| BELLUS HEALTH INC NEW | COM NEW | 07987C204 | 1,484 | 148,666 | SH | SOLE | 1 | 148,666 | 0 | 0 | |
| CUE BIOPHARMA INC | COM | 22978P106 | 11,636 | 820,000 | SH | SOLE | 1 | 820,000 | 0 | 0 | |
| EPIZYME INC | COM | 29428V104 | 3,567 | 230,000 | SH | SOLE | 1 | 230,000 | 0 | 0 | |
| GRAYSCALE BITCOIN ORD | COM | 389637109 | 4,201 | 590,000 | SH | SOLE | 1 | 590,000 | 0 | 0 | |
| MAXAR TECHNOLOGIES INC | COM | 57778K105 | 18,040 | 1,689,100 | SH | SOLE | 1 | 1,689,100 | 0 | 0 | |
| PIERIS PHARMACEUTICALS INC | COM | 720795103 | 4,063 | 1,781,921 | SH | SOLE | 1 | 1,781,921 | 0 | 0 | |
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 27,425 | 190,000 | SH | SOLE | 1 | 190,000 | 0 | 0 | |
| SCHRODINGER ORD | COM | 80810D103 | 2,587 | 60,000 | SH | SOLE | 1 | 60,000 | 0 | 0 | |
| SUNESIS PHARMACEUTICALS INC | COM | 867328700 | 1,254 | 3,021,692 | SH | SOLE | 1 | 3,021,692 | 0 | 0 | |
| TESLA INC | COM | 88160R101 | 1,048 | 2,000 | SH | SOLE | 1 | 2,000 | 0 | 0 | |